Periostin in Eye Diseases

被引:5
作者
Yoshida, Shigeo [1 ]
Umeno, Yumi [1 ]
Haruta, Masatoshi [1 ]
机构
[1] Kurume Univ, Sch Med, Dept Ophthalmol, Kurume, Fukuoka, Japan
来源
PERIOSTIN | 2019年 / 1132卷
关键词
Vitreoretinal disease; Genome-wide gene expression profiling; Proliferative diabetic retinopathy; Proliferative vitreoretinopathy; Age-related macular degeneration; Fibrovascular membranes; Epiretinal membranes; Neovascularization; Fibrosis; Retina; Choroid; Cornea; Conjunctiva; Pterygia; Glaucoma; Corneal dystrophy; Atopic keratoconjunctivitis; IL-4; IL-13; Serum; Tear; Mouse model of oxygen-induced retinal neovascularization; Mouse model of laser-induced choroidal neovascularization; Single-stranded RNA interference; PROLIFERATIVE DIABETIC-RETINOPATHY; PIGMENT EPITHELIAL-CELLS; TOLL-LIKE RECEPTOR-3; FIBROVASCULAR MEMBRANES; MOUSE MODEL; RNA INTERFERENCE; ANGIOGENESIS SUPPRESSION; MATRICELLULAR PROTEINS; MACROPHAGE PLASTICITY; EPIRETINAL MEMBRANES;
D O I
10.1007/978-981-13-6657-4_12
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transparency of the eye can be disturbed by several eye diseases. It has recently been reported that periostin plays pivotal roles in the pathogenesis of several eye disease, such as diabetic retinopathy (DR), age-related macular degeneration (AMD), glaucoma, pterygia, corneal dystrophy, and chronic ocular allergic diseases. In these diseases, formation of fibro (vascular) tissue plays an important role. Gene expression profiling of human retinal fibro (vascular) membrane revealed significant up-regulation of periostin. The expression of periostin after environmental perturbations, including IL-4 and/or IL-13 induction, can alter normal physiological interactions among fibroblasts, macrophages and ECM protein in the eye. Modulating the expression of periostin by low-molecular weight compounds, antibodies or RNAi directed against the molecule could be a novel therapeutic strategy for inhibiting the progression of those periostin-involved eye diseases.
引用
收藏
页码:113 / 124
页数:12
相关论文
共 50 条
[21]   Lutein Supplementation for Eye Diseases [J].
Li, Long Hin ;
Lee, Jetty Chung-Yung ;
Leung, Ho Hang ;
Lam, Wai Ching ;
Fu, Zhongjie ;
Lo, Amy Cheuk Yin .
NUTRIENTS, 2020, 12 (06) :1-27
[22]   An Altered Neurovascular System in Aging-Related Eye Diseases [J].
Choi, Yoon Kyung .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
[23]   The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain [J].
Maran, Jack J. ;
Adesina, Moradeke M. ;
Green, Colin R. ;
Kwakowsky, Andrea ;
Mugisho, Odunayo O. .
AGEING RESEARCH REVIEWS, 2023, 88
[24]   Physical activity and eye diseases. The Beijing Eye Study [J].
Wang, Ya Xing ;
Wei, Wen Bin ;
Xu, Liang ;
Jonas, Jost B. .
ACTA OPHTHALMOLOGICA, 2019, 97 (03) :325-331
[25]   Periostin in Skin Tissue and Skin-Related Diseases [J].
Yamaguchi, Yukie .
ALLERGOLOGY INTERNATIONAL, 2014, 63 (02) :161-170
[26]   Periostin: A Potential Biomarker and Therapeutic Target in Pulmonary Diseases [J].
Alzobaidi, Nafaa ;
Rehman, Sana ;
Naqvi, Maaz ;
Gulati, Kavita ;
Ray, Arunabha .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2022, 25 :137-148
[27]   Dispensing treatments for chronic eye diseases [J].
Layrolle, Alexia .
ACTUALITES PHARMACEUTIQUES, 2022, 61 (620) :28-32
[28]   DNA Damage and Repair in Eye Diseases [J].
Sohn, Joanna ;
Lee, Sang-Eun ;
Shim, Eun-Yong .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
[29]   Antineovascular agents in the treatment of eye diseases [J].
Eichler, Wolfram ;
Yafai, Yousef ;
Wiedemann, Peter ;
Fengler, Doerte .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (21) :2645-2660
[30]   Proteomics profiling of vitreous humor reveals complement and coagulation components, adhesion factors, and neurodegeneration markers as discriminatory biomarkers of vitreoretinal eye diseases [J].
Santos, Fatima M. ;
Ciordia, Sergio ;
Mesquita, Joana ;
Cruz, Carla ;
Sousa, Joao Paulo Castro e ;
Passarinha, Luis A. ;
Tomaz, Candida T. ;
Paradela, Alberto .
FRONTIERS IN IMMUNOLOGY, 2023, 14